CTOs on the Move


 
Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.abcuro.com
  • 90 Bridge Street Suite 100
    Newton, AB USA 02458
  • Phone: 617.714.9759

Executives

Name Title Contact Details

Funding

Abcuro raised $42M on 01/07/2021

Similar Companies

Adrian Elwell at Au Top

Adrian Elwell at Au Top is a Danville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Checkerspot

Checkerspot is a design-centric materials company enabling ultra-high performance consumer products.

The DNA Repair Company

The DNA Repair Company is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Array Biopharma

Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. We have locations in CO (Boulder and Longmont), MA (Boston), and NC (Morrisville).

Nurse On Call

Nurse On Call is a Naples, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.